Trials / Recruiting
RecruitingNCT06648317
Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Peking University Cancer Hospital & Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the ability of \[68Ga\]N188 to detect nectin-4 overexpression in patients with lung lesions.
Detailed description
To evaluate the ability of \[68Ga\]N188 to detect nectin-4 overexpression in patients with different lung lesions, such as inflammation and lung cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | FDG-PET | All study participants will undergo 18F-FDG PET/CT scan within 1 week |
Timeline
- Start date
- 2024-11-21
- Primary completion
- 2025-03-01
- Completion
- 2025-12-01
- First posted
- 2024-10-18
- Last updated
- 2024-11-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06648317. Inclusion in this directory is not an endorsement.